Rodrigo Jaimovich

Rodrigo Jaimovich

Auto-generated profile, based on publicly available information

Rodrigo Jaimovich

Red de Salud UC CHRISTUS, Santiago, Chile

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2016 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
PFPablo Florenzano
Pablo Florenzano
FGFrancisco J. Guarda
Francisco J. Guarda
RJRodrigo Jaimovich
Rodrigo Jaimovich
NDNicolás Droppelmann
Nicolás Droppelmann
HGHernán González
Hernán González
JDJosé M. Domínguez
José M. Domínguez
Context. Radioiodine (RAI) administration has adverse effects in patients treated for thyroid cancer (DTC), but there is scarce information regarding their intensity and duration.Objective. To evaluate frequency and intensity of early and late RAI-related symptoms in patients with DTC.Design. Observational prospective study.Patients. DTC patients who underwent thyroidectomy, with or without RAI.Measurements. Patients answered 2 surveys: (1) from 0 to 6 months and (2) between 6 and 18 months after initial treatment.Results. 110 patients answered the first survey and 61 both. Nearly 80 percent received RAI. Among early symptoms, periorbital edema, excessive tearing, salivary gland disturbances, dry mouth, taste disorders, and nausea were more frequent and intense among RAI patients. Regarding late symptoms, periorbital edema, salivary gland pain and swelling, and dry mouth were more frequent and intense in RAI patients. Frequency and intensity of adverse effects were not different between low and high RAI doses (50 versus ≥100 mCi).Conclusion. RAI-related symptoms are frequent and usually persist after 6 months of administration, even when low doses are given. This finding must be considered when deciding RAI administration, especially in low risk patients, among whom RAI benefit is controversial.

1 January 2010 in Revista Española de Medicina Nuclear (English Edition)
Verified
Journal Article
Closed access
RJR. Jaimovich
R. Jaimovich
DGDaniela Gutiérrez G
Daniela Gutiérrez G
HLH. Lavados
H. Lavados
CAC. Aqueveque
C. Aqueveque
LQL. Quevedo
L. Quevedo
TMTeresa Massardo
Teresa Massardo

4 June 2026 in Medwave
Verified
Journal Article
Closed access
NLNicole Lustig
Nicole Lustig
LRLeticia Rincón
Leticia Rincón
JQJuan Carlos Quintana
Juan Carlos Quintana
VIVirginia Iturrieta
Virginia Iturrieta
IFIgnacio Fuentes
Ignacio Fuentes
JDJosé Miguel Domínguez
José Miguel Domínguez